ORTEXORTEX News
Tracking CSTM? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CS
ConfluenceCSTM

CSTM Options Bulls and Short Sellers Collide Ahead of Earnings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 29 Jul 2026, 10:07

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Options traders are betting bullishly on CSTM heading into today's earnings. The put-call ratio has dropped to 0.38 — a 2-year low. That's 2.6 standard deviations below its 20-day mean, a statistically extreme lean toward calls.

Yet short sellers have been moving in the opposite direction all week.

Bulls Own the Options Desk

The PCR 52-week range runs from 0.14 to 1.39. At 0.38, today's reading sits toward the lower end — but not at an absolute extreme. What makes it notable is the speed. The ratio has fallen from 0.46 just ten days ago, a consistent drift that accelerated this week as earnings approached.

Call open interest is dominating. Options traders, on balance, are positioned for an upside print.

Short Sellers Pushed Back In

SI climbed 15% over the past week to 4.8% of free float. That's roughly 6.6 million shares short. The one-month rise is also meaningful — up 10%.

Cost to borrow more than doubled. It sat at 0.48% seven days ago. It now stands at 1.07%. That jump is significant in percentage terms, though the absolute level remains modest.

Availability remains exceptionally loose at 9,293% — roughly 81 million shares still available to borrow. There is no structural squeeze risk here. The CTB move reflects increased demand, not a depleted lending pool.

The short score ticked up to 39.1 this week, from 36.8 the week prior. It's a modest move, but directionally consistent with the rise in short positions.

Analysts Trimmed Targets, Kept the Faith

Wells Fargo and UBS both lowered price targets in early July — Wells Fargo to $37, UBS to $35. Both maintained positive ratings. The consensus mean target stands at $32.56, above the current price of $29.08. That implies roughly 12% upside from here.

JP Morgan downgraded to Neutral in late April. That remains the only negative signal from sell-side coverage in recent months.

Data Summary

  • SI % of free float: 4.8%, up 15% in one week
  • Cost to borrow: 1.07%, up from 0.48% a week ago (+122%)
  • Availability: 9,293% — lending market remains very loose
  • Put-call ratio: 0.38, a 2-year low; z-score –2.6
  • Earnings: Today, 13:30 UTC
  • Price: $29.08, down 8.5% over the past month
  • Analyst consensus: Buy-leaning; mean target $32.56

Two distinct groups are placing their bets ahead of the print. Options traders are leaning heavily toward calls. Short sellers added exposure this week. One of them will be right by end of day.

Stocks in this article

See the live data behind this article on ORTEX.

Open CSTM on ORTEX →

How this article was generated

Generated
29 Jul 2026, 10:08
Data as of
29 Jul 2026, 10:07
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.